Seppo Kopsala

Seppo Kopsala discloses dealings in Optomed Oyj to Nasdaq Helsinki. We count 3 filings; the first trade dates from 7 January 2021 and the latest from 6 May 2022.

The open-market side counts 1 purchase for €6 alongside 2 sales for €5,454. Taken together, the sales exceed the purchases by €5,448. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2022 alone, the filings show 1 purchase and no sales.

Most recently, on 9 May 2022, the filings show an open-market purchase worth €6 in Optomed Oyj. Between a trade and the moment it shows up on Nasdaq Helsinki, the median delay is 3 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by Nasdaq Helsinki and describes the past, not future prices; it is not investment advice.